Symbols / BCPC Stock $173.78 -1.56% Balchem Corporation

Basic Materials • Specialty Chemicals • United States • NMS
BCPC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Basic Materials
Industry Specialty Chemicals
CEO Mr. Theodore Lee Harris
Exch · Country NMS · United States
Market Cap 5.57B
Enterprise Value 5.67B
Income 154.84M
Sales 1.04B
FCF (ttm) 136.12M
Book/sh 39.22
Cash/sh 2.33
Employees 1,352
Insider 10d —
IPO Jun 03, 1986
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 20.21%
P/E 36.66
Forward P/E 28.61
PEG 4.10
P/S 5.37
P/B 4.43
P/C —
EV/EBITDA 22.27
EV/Sales 5.47
Quick Ratio 1.24
Current Ratio 2.07
Debt/Eq 14.37
LT Debt/Eq —
EPS (ttm) 4.74
EPS next Y 6.07
EPS Growth 17.30%
Revenue Growth 9.80%
EPS Gr Q/Q 16.80%
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-20
ROA 8.02%
ROE 12.86%
ROIC —
Gross Margin 35.73%
Oper. Margin 19.84%
Profit Margin 14.93%
Shs Outstand 32.03M
Shs Float 31.80M
Insider Own 0.43%
Instit Own 93.14%
Short Float 1.49%
Short Ratio 1.66
Short Interest 342.85K
52W High 183.90
vs 52W High -5.50%
52W Low 139.17
vs 52W Low 24.87%
Beta 0.95
Impl. Vol. 20.96%
Rel Volume 1.96
Avg Volume 190.12K
Volume 372.95K
Target (mean) $200.50
Tgt Median $202.50
Tgt Low $163.00
Tgt High $234.00
# Analysts 4
Recom None
Prev Close $176.53
Price $173.78
Change -1.56%
About

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$200.50
Mean price target
2. Current target
$173.78
Latest analyst target
3. DCF / Fair value
$76.51
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$173.78
Low
$163.00
High
$234.00
Mean
$200.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-24 main HC Wainwright & Co. Buy → Buy $190
2025-12-05 init Rothschild & Co — → Neutral $162
2025-10-22 main HC Wainwright & Co. Buy → Buy $190
2025-08-04 main HC Wainwright & Co. Buy → Buy $189
2025-04-28 main HC Wainwright & Co. Buy → Buy $180
2025-02-24 reit HC Wainwright & Co. Buy → Buy $190
2024-11-04 main HC Wainwright & Co. Buy → Buy $190
2024-07-31 main HC Wainwright & Co. Buy → Buy $185
2024-05-06 main HC Wainwright & Co. Buy → Buy $170
2024-02-20 main HC Wainwright & Co. Buy → Buy $167
2023-10-30 main HC Wainwright & Co. Buy → Buy $135
2023-07-31 main HC Wainwright & Co. Buy → Buy $165
2023-06-05 main HC Wainwright & Co. Buy → Buy $150
2023-02-27 main HC Wainwright & Co. — → Buy $140
2022-11-07 main HC Wainwright & Co. — → Buy $152
2022-08-22 main HC Wainwright & Co. — → Buy $164
2022-05-02 main HC Wainwright & Co. — → Buy $152
2022-03-08 main HC Wainwright & Co. — → Buy $155
2022-02-22 up Sidoti & Co. Neutral → Buy $175
2022-01-10 main HC Wainwright & Co. — → Buy $170
News
RSS: Latest BCPC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-11 FISCHER DAVID B Director — 870 $0.00 $0
2026-02-11 HARRIS THEODORE L Chief Executive Officer — 25,641 $0.00 $0
2026-02-11 BACKUS WILLIAM A Officer — 2,154 $0.00 $0
2026-02-11 FISH KATHLEEN B Director — 870 $0.00 $0
2026-02-11 WINEINGER MATTHEW DAVID Director — 870 $0.00 $0
2026-02-11 KNUTSON DANIEL E. Director — 870 $0.00 $0
2026-02-11 BENGTSSON CARL MARTIN Chief Financial Officer — 8,328 $0.00 $0
2026-02-11 REID MARTIN LUTHER Officer — 3,299 $0.00 $0
2026-02-11 TIGNOR MICHAEL BRENT Officer — 3,129 $0.00 $0
2026-02-11 VAN GUNSTEREN JOB LEONARD Officer — 1,775 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,037.16
+8.75%
953.68
+3.39%
922.44
-2.11%
942.36
Operating Revenue
1,037.16
+8.75%
953.68
+3.39%
922.44
-2.11%
942.36
Cost Of Revenue
666.53
+7.94%
617.48
-0.47%
620.38
-6.27%
661.91
Reconciled Cost Of Revenue
666.53
+7.94%
617.48
-0.47%
620.38
-6.27%
661.91
Gross Profit
370.63
+10.24%
336.21
+11.31%
302.06
+7.70%
280.45
Operating Expense
161.31
+5.23%
153.30
+7.30%
142.86
+5.62%
135.26
Research And Development
18.51
+10.22%
16.79
+11.59%
15.05
+23.44%
12.19
Selling General And Administration
142.80
+4.61%
136.50
+6.80%
127.81
+3.85%
123.07
Selling And Marketing Expense
75.37
+9.37%
68.92
-7.37%
74.40
+10.37%
67.41
General And Administrative Expense
67.42
-0.24%
67.59
+26.53%
53.42
-4.04%
55.66
Other Gand A
67.42
-0.24%
67.59
+26.53%
53.42
-4.04%
55.66
Total Expenses
827.84
+7.40%
770.77
+0.99%
763.25
-4.26%
797.17
Operating Income
209.33
+14.44%
182.91
+14.90%
159.19
+9.65%
145.19
Total Operating Income As Reported
209.33
+14.44%
182.91
+14.90%
159.19
+9.65%
145.19
EBITDA
254.94
+10.39%
230.95
+7.52%
214.81
+9.67%
195.87
Normalized EBITDA
254.94
+10.39%
230.95
+7.52%
214.81
+9.67%
195.87
Reconciled Depreciation
45.69
-4.76%
47.97
-12.67%
54.94
+5.95%
51.85
EBIT
209.25
+14.36%
182.98
+14.45%
159.87
+11.01%
144.02
Net Income
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Pretax Income
199.03
+19.57%
166.45
+21.27%
137.26
+2.63%
133.75
Net Non Operating Interest Income Expense
-10.22
+38.17%
-16.53
+26.91%
-22.61
-120.23%
-10.27
Interest Expense Non Operating
10.22
-38.17%
16.53
-26.91%
22.61
+120.23%
10.27
Net Interest Income
-10.22
+38.17%
-16.53
+26.91%
-22.61
-120.23%
-10.27
Interest Expense
10.22
-38.17%
16.53
-26.91%
22.61
+120.23%
10.27
Other Income Expense
-0.08
-206.94%
0.07
-89.43%
0.68
+158.25%
-1.17
Other Non Operating Income Expenses
-0.08
-206.94%
0.07
-89.43%
0.68
+158.25%
-1.17
Tax Provision
44.19
+16.34%
37.98
+32.24%
28.72
+1.18%
28.38
Tax Rate For Calcs
0.00
-2.70%
0.00
+9.17%
0.00
-1.42%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Net Income From Continuing Operation Net Minority Interest
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Net Income From Continuing And Discontinued Operation
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Net Income Continuous Operations
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Normalized Income
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Net Income Common Stockholders
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Diluted EPS
—
3.93
+17.31%
3.35
+3.08%
3.25
Basic EPS
—
3.95
+17.37%
3.37
+2.69%
3.28
Basic Average Shares
—
32.53
+0.84%
32.25
+0.32%
32.15
Diluted Average Shares
—
32.72
+0.83%
32.45
+0.17%
32.39
Diluted NI Availto Com Stockholders
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,686.25
+7.04%
1,575.37
-1.37%
1,597.21
-1.68%
1,624.51
Current Assets
365.61
+16.52%
313.77
-0.15%
314.24
-6.42%
335.80
Cash Cash Equivalents And Short Term Investments
74.57
+50.60%
49.52
-23.17%
64.45
-3.17%
66.56
Cash And Cash Equivalents
74.57
+50.60%
49.52
-23.17%
64.45
-3.17%
66.56
Receivables
143.60
+20.00%
119.66
-4.49%
125.28
-4.78%
131.58
Accounts Receivable
143.60
+20.00%
119.66
-4.49%
125.28
-4.78%
131.58
Gross Accounts Receivable
144.46
+19.81%
120.57
-4.45%
126.19
-4.98%
132.80
Allowance For Doubtful Accounts Receivable
-0.86
+5.17%
-0.91
-0.11%
-0.91
+25.94%
-1.23
Inventory
131.45
+0.49%
130.80
+19.43%
109.52
-8.48%
119.67
Raw Materials
41.86
-7.64%
45.32
+14.68%
39.52
-11.15%
44.48
Work In Process
6.53
+44.72%
4.51
+13.89%
3.96
+25.99%
3.14
Finished Goods
83.06
+2.58%
80.97
+22.60%
66.04
-8.33%
72.05
Prepaid Assets
9.78
+21.41%
8.05
+3.28%
7.80
+59.05%
4.90
Hedging Assets Current
—
—
0.00
-100.00%
5.99
Other Current Assets
6.22
+8.44%
5.74
-20.23%
7.19
+1.28%
7.10
Total Non Current Assets
1,320.64
+4.68%
1,261.60
-1.67%
1,282.97
-0.45%
1,288.71
Net PPE
322.84
+7.90%
299.20
+1.12%
295.90
+1.76%
290.79
Gross PPE
580.57
+9.91%
528.20
+3.83%
508.70
+5.92%
480.27
Accumulated Depreciation
-257.73
-12.54%
-229.00
-7.61%
-212.80
-12.30%
-189.48
Properties
0.00
0.00
0.00
0.00
Land And Improvements
12.43
+6.31%
11.69
-0.82%
11.79
+3.26%
11.41
Buildings And Improvements
116.39
+8.83%
106.95
+2.48%
104.36
+15.14%
90.64
Machinery Furniture Equipment
—
—
—
278.85
Construction In Progress
95.23
+22.86%
77.51
+29.22%
59.98
-24.96%
79.93
Other Properties
356.51
+7.37%
332.05
-0.16%
332.57
+11.49%
298.28
Goodwill And Other Intangible Assets
979.66
+3.66%
945.08
-2.58%
970.12
-1.29%
982.80
Goodwill
816.38
+4.66%
780.03
+0.14%
778.91
+1.22%
769.51
Other Intangible Assets
163.29
-1.07%
165.05
-13.68%
191.21
-10.35%
213.29
Other Non Current Assets
18.13
+4.72%
17.32
+2.18%
16.95
+12.10%
15.12
Total Liabilities Net Minority Interest
428.84
+0.79%
425.46
-21.68%
543.23
-20.84%
686.23
Current Liabilities
176.38
+11.86%
157.69
+6.19%
148.49
+6.03%
140.04
Payables And Accrued Expenses
144.67
+10.04%
131.47
+3.49%
127.04
+6.33%
119.48
Payables
95.38
+8.73%
87.72
+1.78%
86.19
+4.18%
82.73
Accounts Payable
60.42
+10.38%
54.74
-1.37%
55.50
-3.17%
57.32
Dividends Payable
31.04
+8.89%
28.51
+10.86%
25.72
+11.19%
23.13
Current Accrued Expenses
49.29
+12.66%
43.75
+7.09%
40.85
+11.19%
36.74
Pensionand Other Post Retirement Benefit Plans Current
27.90
+21.89%
22.89
+32.84%
17.23
+4.13%
16.54
Total Tax Payable
3.91
-12.40%
4.47
-10.09%
4.97
+117.85%
2.28
Income Tax Payable
3.91
-12.40%
4.47
-10.09%
4.97
+117.85%
2.28
Current Debt And Capital Lease Obligation
3.82
+14.75%
3.33
-21.16%
4.22
+4.95%
4.02
Current Capital Lease Obligation
3.82
+14.75%
3.33
-21.16%
4.22
+4.95%
4.02
Total Non Current Liabilities Net Minority Interest
252.46
-5.72%
267.77
-32.16%
394.74
-27.73%
546.19
Long Term Debt And Capital Lease Obligation
176.87
-13.60%
204.72
-37.23%
326.11
-28.58%
456.59
Long Term Debt
164.00
-13.68%
190.00
-38.62%
309.57
-29.73%
440.57
Long Term Capital Lease Obligation
12.87
-12.56%
14.72
-11.05%
16.54
+3.28%
16.02
Non Current Deferred Liabilities
54.14
+23.83%
43.72
-15.99%
52.05
-17.10%
62.78
Non Current Deferred Taxes Liabilities
54.14
+23.83%
43.72
-15.99%
52.05
-17.10%
62.78
Other Non Current Liabilities
21.44
+10.91%
19.34
+16.64%
16.58
-38.18%
26.81
Stockholders Equity
1,257.41
+9.35%
1,149.91
+9.10%
1,053.98
+12.33%
938.28
Common Stock Equity
1,257.41
+9.35%
1,149.91
+9.10%
1,053.98
+12.33%
938.28
Capital Stock
2.14
-1.43%
2.17
+0.84%
2.15
+0.33%
2.15
Common Stock
2.14
-1.43%
2.17
+0.84%
2.15
+0.33%
2.15
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
32.06
-1.44%
32.53
+0.84%
32.25
+0.32%
32.15
Ordinary Shares Number
32.06
-1.44%
32.53
+0.84%
32.25
+0.32%
32.15
Additional Paid In Capital
92.33
-46.94%
174.00
+19.46%
145.65
+13.08%
128.81
Retained Earnings
1,121.40
+12.42%
997.49
+11.14%
897.49
+10.19%
814.49
Gains Losses Not Affecting Retained Earnings
41.55
+274.96%
-23.75
-373.24%
8.69
+221.48%
-7.15
Other Equity Adjustments
41.55
+274.96%
-23.75
-373.24%
8.69
+221.48%
-7.15
Total Equity Gross Minority Interest
1,257.41
+9.35%
1,149.91
+9.10%
1,053.98
+12.33%
938.28
Total Capitalization
1,421.41
+6.08%
1,339.91
-1.73%
1,363.55
-1.11%
1,378.85
Working Capital
189.23
+21.24%
156.09
-5.83%
165.75
-15.33%
195.76
Invested Capital
1,421.41
+6.08%
1,339.91
-1.73%
1,363.55
-1.11%
1,378.85
Total Debt
180.69
-13.15%
208.04
-37.02%
330.33
-28.28%
460.61
Net Debt
89.43
-36.34%
140.49
-42.69%
245.12
-34.46%
374.01
Capital Lease Obligations
16.69
-7.52%
18.04
-13.10%
20.77
+3.61%
20.04
Net Tangible Assets
277.75
+35.60%
204.83
+144.24%
83.86
+288.38%
-44.52
Tangible Book Value
277.75
+35.60%
204.83
+144.24%
83.86
+288.38%
-44.52
Derivative Product Liabilities
—
—
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
216.56
+18.99%
182.00
-0.96%
183.76
+32.64%
138.54
Cash Flow From Continuing Operating Activities
216.56
+18.99%
182.00
-0.96%
183.76
+32.64%
138.54
Net Income From Continuing Operations
154.84
+20.53%
128.47
+18.36%
108.54
+3.01%
105.37
Depreciation Amortization Depletion
45.69
-4.76%
47.97
-12.67%
54.94
+5.95%
51.85
Depreciation And Amortization
45.69
-4.76%
47.97
-12.67%
54.94
+5.95%
51.85
Other Non Cash Items
—
-0.09
+99.19%
-11.30
—
Stock Based Compensation
18.06
+8.29%
16.68
+3.88%
16.05
+21.39%
13.22
Provisionand Write Offof Assets
-0.10
-132.44%
0.30
+708.11%
0.04
-90.77%
0.40
Asset Impairment Charge
—
—
7.03
+30469.57%
0.02
Deferred Tax
6.26
+192.37%
-6.78
+37.31%
-10.81
-29.32%
-8.36
Deferred Income Tax
6.26
+192.37%
-6.78
+37.31%
-10.81
-29.32%
-8.36
Operating Gains Losses
-0.74
-147.19%
1.56
-75.17%
6.30
+392.03%
1.28
Net Foreign Currency Exchange Gain Loss
-0.68
-580.00%
-0.10
+86.36%
-0.73
-180.20%
0.91
Change In Working Capital
-7.46
-22.00%
-6.12
-130.57%
20.01
+179.34%
-25.22
Change In Receivables
-20.85
-473.58%
5.58
-19.90%
6.97
+292.62%
-3.62
Changes In Account Receivables
-20.85
-473.58%
5.58
-19.90%
6.97
+292.62%
-3.62
Change In Inventory
3.63
+115.95%
-22.79
-316.44%
10.53
+234.93%
-7.80
Change In Prepaid Assets
-1.33
-692.00%
0.23
+106.36%
-3.54
-289.30%
1.87
Change In Payables And Accrued Expense
11.29
+24.57%
9.06
+155.21%
3.55
+122.85%
-15.54
Change In Other Working Capital
-0.20
-111.38%
1.80
-27.89%
2.50
+2067.72%
-0.13
Investing Cash Flow
-43.89
+26.53%
-59.74
-71.59%
-34.81
+91.63%
-416.01
Cash Flow From Continuing Investing Activities
-43.89
+26.53%
-59.74
-71.59%
-34.81
+91.63%
-416.01
Capital Expenditure
-43.49
-21.95%
-35.66
+5.89%
-37.89
+24.13%
-49.95
Capital Expenditure Reported
-43.49
-21.95%
-35.66
+5.89%
-37.89
+24.13%
-49.95
Net Investment Purchase And Sale
0.00
0.00
-100.00%
2.74
0.00
Sale Of Investment
0.00
0.00
-100.00%
2.74
0.00
Net Business Purchase And Sale
-0.68
+97.23%
-24.43
-1484.57%
-1.54
+99.58%
-366.27
Purchase Of Business
-0.68
+97.23%
-24.43
-1484.57%
-1.54
+99.58%
-366.27
Net Other Investing Changes
0.27
-23.68%
0.36
-80.91%
1.88
+813.11%
0.21
Financing Cash Flow
-152.81
-14.19%
-133.81
+12.72%
-153.32
-162.15%
246.68
Cash Flow From Continuing Financing Activities
-152.81
-14.19%
-133.81
+12.72%
-153.32
-162.15%
246.68
Net Issuance Payments Of Debt
-26.19
+78.13%
-119.78
+8.72%
-131.22
-143.62%
300.83
Issuance Of Debt
88.00
+238.46%
26.00
+44.44%
18.00
-95.86%
435.00
Repayment Of Debt
-114.19
+21.67%
-145.78
+2.30%
-149.22
-11.22%
-134.16
Long Term Debt Issuance
88.00
+238.46%
26.00
+44.44%
18.00
-95.86%
435.00
Long Term Debt Payments
-114.19
+21.67%
-145.78
+2.30%
-149.22
-11.22%
-134.16
Net Long Term Debt Issuance
-26.19
+78.13%
-119.78
+8.72%
-131.22
-143.62%
300.83
Net Common Stock Issuance
-107.64
-1794.33%
-5.68
-27.14%
-4.47
+87.38%
-35.42
Common Stock Payments
-107.64
-1794.33%
-5.68
-27.14%
-4.47
+87.38%
-35.42
Common Stock Dividend Paid
-28.29
-10.60%
-25.58
-11.82%
-22.87
-10.42%
-20.71
Cash Dividends Paid
-28.29
-10.60%
-25.58
-11.82%
-22.87
-10.42%
-20.71
Repurchase Of Capital Stock
-107.64
-1794.33%
-5.68
-27.14%
-4.47
+87.38%
-35.42
Proceeds From Stock Option Exercised
9.31
-45.98%
17.23
+228.65%
5.24
+63.20%
3.21
Net Other Financing Charges
—
—
—
-1.23
Changes In Cash
19.86
+271.88%
-11.55
-164.17%
-4.37
+85.80%
-30.80
Effect Of Exchange Rate Changes
5.20
+253.85%
-3.38
-249.56%
2.26
+138.44%
-5.88
Beginning Cash Position
49.52
-23.17%
64.45
-3.17%
66.56
-35.53%
103.24
End Cash Position
74.57
+50.60%
49.52
-23.17%
64.45
-3.17%
66.56
Free Cash Flow
173.07
+18.27%
146.34
+0.32%
145.87
+64.65%
88.59
Interest Paid Supplemental Data
10.60
-40.09%
17.70
-31.76%
25.93
+118.31%
11.88
Income Tax Paid Supplemental Data
37.75
-11.48%
42.64
+19.36%
35.73
+8.21%
33.02
Sale Of Business
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category